8-KMaterial AgreementsOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Material Agreement (Mar 12, 2019)

Filed March 12, 2019For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) announced on March 12, 2019, the issuance of $500,000,000 aggregate principal amount of 4.200% Senior Notes due 2029. This debt offering was conducted under the company's existing shelf registration statement and is intended to provide additional capital for general corporate purposes. The notes are senior unsecured obligations and rank equally with other senior unsecured debt, with interest payments due semi-annually and maturity in 2029. The issuance of these notes is a standard financing activity for a company of Quest Diagnostics' size, aimed at managing its capital structure and potentially funding growth initiatives or refinancing existing debt. Investors should note the covenants within the indenture that may restrict certain future actions, such as significant asset sales or additional debt incurrence. The inclusion of a change of control provision offers some protection to noteholders in the event of a significant corporate change.

Key Highlights

  • 1Quest Diagnostics issued $500 million in 4.200% Senior Notes due 2029.
  • 2The notes were issued on March 12, 2019, under the company's shelf registration statement.
  • 3The debt matures on June 30, 2029, with semi-annual interest payments beginning June 30, 2019.
  • 4The notes are senior unsecured obligations, ranking equally with other senior unsecured debt.
  • 5The Indenture includes covenants that may limit the company's ability to incur certain liens, enter sale/leaseback transactions, merge, or make restricted payments.
  • 6A 'change of control' provision requires the company to offer to repurchase the notes at 101% of principal plus accrued interest if triggered.
  • 7The filing references an underwriting agreement with major financial institutions, indicating a public offering.

Frequently Asked Questions

While the filing does not explicitly state the specific use of proceeds, debt issuances of this nature are typically used for general corporate purposes, which can include funding working capital, capital expenditures, potential acquisitions, refinancing existing debt, or returning capital to shareholders.

This issuance increases the company's total debt by $500 million. Investors should review the company's overall debt-to-equity ratio and other leverage metrics in subsequent financial statements to assess the impact on its financial risk profile. The interest rate of 4.200% is relatively moderate, which is positive.

The notes are senior unsecured obligations, meaning they have a priority claim over equity holders in case of bankruptcy but are subordinate to secured debt. Key protections include semi-annual interest payments, a defined maturity date, and covenants within the Indenture that restrict certain company actions. Additionally, a change of control provision requires the company to repurchase the notes at a premium if a significant ownership change occurs.

Yes, the indenture contains several covenants that could restrict the company's future financial and operational flexibility. These include limitations on creating liens, engaging in sale and leaseback transactions, consolidating or transferring assets, incurring debt in non-guarantor subsidiaries, and making restricted payments. Investors should refer to the full indenture for precise details.